Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Endosomal TLRs play an important role in innate immune response as well as in autoimmune processes. In the therapy of systemic lupus erythematosus, antimalarial drugs chloroquine, hydroxychloroquine, and quinacrine have been used for a long time. Their suppression of endosomal TLR activation has been attributed to the inhibition of endosomal acidification, which is a prerequisite for the activation of these receptors. We discovered that chloroquine inhibits only activation of endosomal TLRs by nucleic acids, whereas it augments activation of TLR8 by a small synthetic compound, R848. We detected direct binding of antimalarials to nucleic acids by spectroscopic experiments and determined their cellular colocalization. Further analysis revealed that other nucleic acid-binding compounds, such as propidium iodide, also inhibited activation of endosomal TLRs and colocalized with nucleic acids to endosomes. We found that imidazoquinolines, which are TLR7/8 agonists, inhibit TLR9 and TLR3 even in the absence of TLR7 or TLR8, and their mechanism of inhibition is similar to the antimalarials. In contrast to bafilomycin, none of the tested antimalarials and imidazoquinolines inhibited endosomal proteolysis or increased the endosomal pH, confirming that inhibition of pH acidification is not the underlying cause of inhibition. We conclude that the direct binding of inhibitors to nucleic acids mask their TLR-binding epitope and may explain the efficiency of those compounds in the treatment…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In phagocytic cells, the deacidification of endosomes using pharmacological inhibitors like chloroquine has been shown to reduce endosomal toll-like receptor (TLR) response (de Bouteiller et al., 2005; Fox, 2019; Kuznik et al., 2011; Wozniacka et al., 2006; Yang et al., 2016)”
From NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load (2021) · cites this paper as Kuznik et al., 2011
In the citing paper
“Hydroxychloroquine (HCQ) is an approved anti-malaria drug, and accumulation of hydroxychloroquine inhibits the binding ability of TLR9 to DNA and subsequent immune activation (77).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [77]
Citations
Cites
Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., & Akira, S. (2002) · Nature Immunology · doi:10.1038/ni758 · Cited by 2,522
ACIDIFICATION OF THE ENDOCYTIC AND EXOCYTIC PATHWAYS
Mellman, I., Fuchs, R., & Helenius, A. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.003311 · Cited by 2,032
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., & Marshak-Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,900
Yoshimori, T., Yamamoto, A., Moriyama, Y., Futai, M., & Tashiro, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47429-2 · Cited by 1,328
Toll-like receptors in systemic autoimmune disease
Marshak-Rothstein, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1957 · Cited by 1,116
Barrat, F. J., Meeker, T., Gregorio, J., Chan, J. H., Uematsu, S., Akira, S., Chang, B., Duramad, O., & Coffman, R. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050914 · Cited by 928
Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
Means, T. K., Latz, E., Hayashi, F., Murali, M. R., Golenbock, D. T., & Luster, A. D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523025 · Cited by 849
Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8
Gorden, K. B., Gorski, K. S., Gibson, S. J., Kedl, R. M., Kieper, W. C., Qiu, X., Tomai, M. A., Alkan, S. S., & Vasilakos, J. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1259 · Cited by 683
Häcker, H., Mischak, H., Miethke, T., Liptay, S., Schmid, R., Sparwasser, T., Heeg, K., Lipford, G. B., & Wagner, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6230 · Cited by 653
The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor
Ewald, S. E., Lee, B. L., Lau, L., Wickliffe, K. E., Shi, G.-P., Chapman, H. A., & Barton, G. M. (2008) · Nature · doi:10.1038/nature07405 · Cited by 617
Research works printed but not linked: 2
- Ahmad-Nejad, 2002, Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments, Eur. J. Immunol., 32, 1958, 10.1002/1521-4141(200207)32:7<1958::aid-immu1958>3.0.co;2-u · DOI · Paper page
- Peacocke, 1973, Acridines, 723
Cited by
Items 501–600 of 627
Smith, M. A., Meliopoulos, V., Tan, S., Bub, T., Brigleb, P. H., Sharp, B., Crawford, J. C., Prater, M. S., Pruett‐Miller, S. M., & Schultz‐Cherry, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.28.555098 · Cited by 2
Kumar, S. S., Elumalai, K., Eluri, K., Elumalai, M., Mallu, K., Srinivasan, S., Ranjan, C., & Sivannan, S. (2020) · Precision Medical Sciences · doi:10.1002/prm2.12024 · Cited by 1
sTLR9 on maternal Circulating immune cells as a negative regulatory phenotype during pregnancy
Wang, H., Lu, W., Zhu, M., Yu, Y., & Wang, L. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05858-8 · Cited by 1
Role of antimalarials in lupus nephritis: a narrative review
Salman-Monte, T. C., Márquez, E., & Rodríguez, E. (2025) · Clinical Rheumatology · doi:10.1007/s10067-025-07711-6 · Cited by 1
Kao, Y.-T., Chen, W., Shie, C.-T., & Yu, C.-Y. (2025) · Journal of Innate Immunity · doi:10.1159/000549390 · Cited by 1
Li, R., Jia, Y., Wu, X., Wang, M., Deng, C., Peng, Y., Zhao, L., Zhang, W., Zhou, J., Li, M., et al. (2025) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/ric794 · Cited by 4
Mingming, M., Luo, Q., Huang, M., Chen, L., Liang, W., Zhong, Y., Liu, F., & Guan, B. (2026) · BMC Nephrology · doi:10.1186/s12882-025-04727-7 · Cited by 1
Popović, K. J., Popović, D. J., Miljković, D., Popović, J. K., Poša, M., Drljača, J., & Dolićanin, Z. (2026) · Pharmaceuticals · doi:10.3390/ph19030407 · Cited by 1
Ochiai, K., Watanabe, K., Nanaumi, S., & Kanayama, M. (2026) · International Archives of Allergy and Immunology · doi:10.1159/000551443 · Cited by 1
Huang, F., Sun, K., Diao, L., Lu, K., Fan, Y., & Xie, G. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1928003 · Cited by 2
Konventionelle Basistherapie der rheumatoiden Arthritis
Keyßer, G. (2012) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-011-0878-3 · Cited by 1
Value of Antimalarial Drugs in the Treatment of Lupus
Paz, Z. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801917-7.00060-7 · Cited by 1
Adaptive and Innate Immune Systems
Kataoka, T. (2017) · Springer eBooks · doi:10.1007/978-4-431-56529-1_5 · Cited by 1
Proskurina, A. S., Orishchenko, К. E., Potter, E. A., Долгова, Е. В., Spaselnikova, A. V., Ritter, G. S., Анатольевич, В. Н., Ryabicheva, T. G., Leplina, O. Y., Ostanin, A. A., et al. (2017) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vj17.289 · Cited by 1
Hydroxychloroquine: A review of its effects on viral replication based on current literature
Ghose, M., Patel, M., & NUGENT, K. M. (2020) · The Southwest Respiratory and Critical Care Chronicles · doi:10.12746/swrccc.v8i36.777 · Cited by 1
Efficient Modified-mRNA Transfection in Neural Stem Cells
Khayamabed, R., Rezaie, N., Poorgolizadeh, E., Moghadam, F. H., Dorminani, K., & Nasr‐Esfahani, M. H. (2021) · Physiology and Pharmacology · doi:10.52547/phypha.27.1.5 · Cited by 1
Liu, M., Liao, M. J., Fisher, C. J., Miguel, R. D. V., & Cherpes, T. L. (2022) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2022.106439 · Cited by 1
Péricardite récurrente idiopathique : revue de littérature et expérience genevoise
Dominati, A., Meyer, P., & Seebach, J. D. (2022) · JMIG · doi:10.53738/revmed.2022.18.776.660 · Cited by 1
Eschbach, J., Wagner, A., Beahr, C., Bekel, A., Korganow, A., Quartier, A., Peter, J., & Eftekhari, P. (2024) · Drug Development Research · doi:10.1002/ddr.22151 · Cited by 1
Venturini, S., Orso, D., Cugini, F., Fabro, G. D., Callegari, A., Reffo, I., Villalta, D., Santi, L. D., Pontoni, E., Giordani, D., et al. (2024) · Clinical Pathology · doi:10.1177/2632010x241304958 · Cited by 1
Takenaka, Y., Tanaka, T., Otaki, S., Kanbe, A., Morita, T., Yokoi, K., Sekiguchi, S., Nakamura, K., Satoh, H., Tojo, T., et al. (2024) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b24-00639 · Cited by 1
Delayed seropositive lupus nephritis: a clinical dilemma
Bhattacharyya, A., Gadalla, R. S. T., Sharma, I., Lockwood, M. M., Kwon, D., & Pourafshar, N. (2025) · BMJ Case Reports · doi:10.1136/bcr-2024-261398 · Cited by 1
Measures that could prevent the next viral pandemic
Leitzke, M. (2025) · Discover Viruses. · doi:10.1007/s44370-025-00024-x · Cited by 1
Role of Toll-Like Receptors in Molecular and Cellular Mechanisms of Respiratory Diseases
Kanwar, I. L., Haider, T., Pandey, V., Gupta, P. N., & Soni, V. (2021) · Springer eBooks · doi:10.1007/978-981-33-6827-9_31 · Cited by 1
A Review on Hydroxychloroquine Drug: to Combat COVID-19
(2020) · Letters in Applied NanoBioScience · doi:10.33263/lianbs94.17051716 · Cited by 1
Value of antimalarial drugs in the treatment of lupus
Hassan, F., Naffaa, M. E., & Paz, Z. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814551-7.00062-3 · Cited by 1
Hidroxicloroquina: uma nova perspetiva no LES
Costa, A. F. S. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/vfk1-hy05 · Cited by 2
Interferon Type I Driven Immune Activation in Generalized Autoimmune Diseases
Brkić, Z. (2010) · RePub (Erasmus University Rotterdam) · Cited by 1
Herster, F., Bittner, Z., Dickhöfer, S., Eise, D., Eigenbrod, T., Knorpp, T., Schneiderhan‐Marra, N., Loeffler, M. W., Kalbacher, H., Hartl, D., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/324814 · Cited by 1
Liu, W., Wen, D., Liu, Z., Wang, K., & Wang, J. (2021) · Research Square · doi:10.21203/rs.3.rs-205060/v1 · Cited by 1
Management of cutaneous lupus erythematosus
Chong, B. F., & Werth, V. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93232-5.00068-x · Cited by 2
Immunostimulatory effects of non-CpG oligodeoxynucleotides on cobia (Rachycentron canadum)
Byadgi, O. V., Chang, C.-I., Lee, J., Huang, C. J., & Cheng, T. (2015) · Aquaculture International · doi:10.1007/s10499-015-9950-3
RO52/ TRIM21 IN B CELL PATHOLOGY
Brauner, S. (2013) · Figshare
Antimalarials: Reversing the autoimmune “mal-area”?
Shrivastava, A., & Khanna, D. (2012) · Indian Journal of Rheumatology · doi:10.1016/j.injr.2012.04.004
Implication des cellules NK au cours des maladies auto-immunes
Hervier, B. (2014) · theses.fr (ABES) · doi:10.70675/dd90485fzdb84z43bez9165z93151d3e9abc · Cited by 1
The Toll of too much Interferon
Maria, N. I. (2015) · EUR Research Repository (Erasmus University Rotterdam)
Konventionelle Basistherapie der rheumatoiden Arthritis Wirkungen in und außerhalb der Zelle
Müller‐Ladner, U. (2012)
Endosomes and Toll-Like Receptors-Role in Autoimmunity
Malemud, C. J. (2015) · Rheumatology Current Research · doi:10.4172/2161-1149.1000158
Chaleuil, A. C. (2014)
Parks, H. (2014) · OakTrust (Texas A&M University Libraries)
Zika Virus: An Emerging Vector Borne Disease
Nanthini Devi, P., & Chitralekha, S. (2023) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.8275175
Infections in Patients with Autoimmune Diseases
Parikh, N. U., Sands, M. F., & Schwartz, S. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-77674-3_14
Oligonucleotide-based Toll-like Receptor Antagonists and Therapeutic Applications
Kandimalla, E. R., & Agrawal, S. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788015714-00080
Rewriting the rule book for Sjögren's syndrome? The promise of new approaches to old treatments
Rasmussen, A. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30081-3
Devlin, A., Ramsey‐Goldman, R., & Costenbader, K. H. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384978-6.00053-4
Rôle de l’autophagie dans la biogenèse des vésicules membranaires apoptotiques
Beillevaire, D. (2019) · doi:10.71781/31623
RNA/DNA sensing in SLE—Toll-like receptors and beyond
Jefferies, C. A., & Sharabi, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814551-7.00020-9
Antipalúdicos de síntesis en dermatología
Chasset, F., Costedoat-Chalumeau, N., & Francès, C. (2020) · EMC - Dermatología · doi:10.1016/s1761-2896(20)44054-3
Singh, S., Chandrashekharaiah, P. S., Paul, V., Kodgire, S., Kushwaha, S., Sanyal, D., & Dasgupta, S. (2020) · doi:10.21467/preprints.201
Safety and Utility of Chloroquine/ Hydroxychloroquine in Palliative Care Patients
Prommer, E. (2020) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909120952773
van der Heijden, E. H. M. (2020) · Utrecht University Repository (Utrecht University) · doi:10.33540/204
Utilización de agonistas de receptores tipo toll 3 en escenarios terapéuticos antitumorales
Nocera, D. A. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Immunomodulatory Responses Of Toll Like Receptors Against 2019nCoV
Maghraby, A. S. (2021) · Russian Open Medical Journal · doi:10.15275/rusomj.2021.0202
Innate Immune Dysregulation in Sjögren’s Syndrome
Kiripolsky, J., & Kramer, J. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-72029-2_5
Passively acquired lupus in the fetus and neonate
Buyon, J. P., Wainwright, B. J., Saxena, A., & Izmirly, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820583-9.00003-8
Wakiya, R., Ueeda, K., Shimada, H., Nakashima, S., Kameda, T., Mansour, M. M. F., Kato, M., Miyagi, T., Sugihara, K., Mizusaki, M., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-942050/v1
Efficacies of repurposing chloroquine analogues for the treatment of COVID-19: Facts and mythsPreprint
Al‐Bari, M. A. A. (2020) · doi:10.22541/au.158679942.29108396
Effects of systemic drugs on the development of drug-induced retinopathy
Bikbov, M. M., Gizzatov, A. V., & Zainullin, R. M. (2022) · Russian Annals of Ophthalmology · doi:10.17116/oftalma202213802194
Overbury, R. S., Pupaibool, J., Hansen, C. B., & Lebiedz‐Odrobina, D. (2021) · Research Square · doi:10.21203/rs.3.rs-152712/v1
皮膚エリテマトーデスおよび全身性エリテマトーデスに対するヒドロキシクロロキン使用のための簡易ガイドライン
Sawada, H. (2017) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.106.2201
Chighizola, C. B., & Ubiali, T. (2014) · Rare diseases of the immune system · doi:10.1007/978-3-319-11044-8_18
Jiang, J., Wang, D., Wang, S., Ye, Z., Mao, X., Zhao, X., & Zhang, H. (2022) · Research Square · doi:10.21203/rs.3.rs-2134082/v1
Therapeutic Targeting of Plasmacytoid Dendritic Cells
Ganguly, D. (2022) · Springer eBooks · doi:10.1007/978-981-19-5595-2_9
Hydroxychloroquine: Chemistry and Medicinal Applications
Singh, R., Tyagi, Y. K., & Yadav, N. (2023) · Heterocycles · doi:10.3987/rev-22-993
Immunopathogenesis of systemic lupus erythematosus
Akhtari, M., Farhadi, E., & Mahmoudi, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85831-1.00014-0
Exploring the Link Between Malaria and COVID-19
Arslan, O. E. (2023) · Springer eBooks · doi:10.1007/978-3-031-20537-8_14
Possible therapeutic targets for SARS-CoV-2 infection and COVID-19
Khan, N., Kumar, N., & Geiger, J. D. (2021) · doi:10.46439/allergy.2.028
Essential role of an acidic endosomal environment in JAK3-mediated signal transductionPreprint
Amano, Y., Tanaka, N., Takeshita, T., & Kojima, K. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.07.556780
Valizadeh, M., Tarjoman, T., Farhoudi, B., Chouhdari, A., Mesgarian, M., SeyedAlinaghi, S., Zangeneh, M., Hanifezadeh, Z., Atashi, H. A., Massumi-Naini, H., et al. (2023) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-etp-14481
How COVID-19 and malaria are strikingly alike: A short review
Hidig, S. M. (2024) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2024.21.1.0037
The Use of Dopaminergic Drugs for Treating Cutaneous Discoid Lupus Erythematosus: A Case Study
Check, J. H., Neumann, B., & CHECK, D. L. (2024) · Journal of Medical - Clinical Research & Reviews · doi:10.33425/2639-944x.1366
Antibiotics and Antimicrobials as Immunomodulators
Chopra, D., Seth, N., Elman, S. A., & Lev‐Tov, H. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-66590-5_8
Methodological aspects of precision medicine with application to primary Sjögren’s disease
Boudjeniba, C. (2023) · theses.fr (ABES) · doi:10.70675/30194fc5z321ez4681zbd71z070fc88766cd
Research Progress of Type I Interferon in Systemic Lupus Erythematosus
孙, 颖. (2024) · Journal of Clinical Personalized Medicine · doi:10.12677/jcpm.2024.34226
Kim, K. E., & Ahn, S. J. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2544044
Zhang, R., Yang, Y., Yan, Y., Wan, H., Yan, W., Luo, K., Zou, H., & Xu, G. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04509-1
Hydroxychloroquine decouples reactogenicity from efficacy in mRNA and viral-vector gene deliveryPreprint
Lainšček, D., Malenšek, Š., Golob-Urbanc, A., Orehek, S., Bohinc, J., Keber, M. M., Sotošek, T., Esih, H., Forstnerič, V., Pečan, P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.10.687670
Self-citationJi, Y., Wang, Q., Lin, R., Pang, M., Sun, L., Gong, J., Ma, H., Fung, S., & Yang, H. Y. (2025) · Journal of Functional Biomaterials · doi:10.3390/jfb16120450
Bourke, L. (2014) · UCL Discovery (University College London)
Acknowledging the Clinical Heterogeneity of Lupus Erythematosus
Wenzel, J. (2015) · Springer eBooks · doi:10.1007/978-3-662-45840-2_9
Trauma-induced inflammation: From targeted therapy for muscle repair to B cells in bone healing
Ort, M.-J. (2025) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-47282
Overbury, R. S., Stoddard, G. J., Pupaibool, J., Hansen, C. B., & Lebiedz‐Odrobina, D. (2021) · Figshare · doi:10.6084/m9.figshare.16569754
Overbury, R. S., Stoddard, G. J., Pupaibool, J., Hansen, C. B., & Lebiedz‐Odrobina, D. (2021) · Figshare · doi:10.6084/m9.figshare.16569757
Pathophysiologische, diagnostische und therapeutische Aspekte neuroinfektiologischer Erkrankungen
Masouris, I. (2025) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.36043
Ruiz Arruza, I. (2024) · Communities in ADDI (University of the Basque Country)
Discovery of Triazine-Based Toll-Like Receptor 9 Antagonists with Oral Activity
Mandler, M. D., Zhu, Y., Hollenbeck, E. C., Ziegler, M., Posy, S., Mukundan, S., Halpern, O. S., Driscoll, J. P., Wang, T., Huang, L., et al. (2026) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5c00760
Guerrier, T. (2012) · theses.fr (ABES) · doi:10.70675/40d587e2zac94z4616zb4f6zb2bb22999c67 · Cited by 1
Etude de l'interaction du virus de l'hépatite C sur les cellules plasmacytoides dendritiques
Florentin, J. (2013) · theses.fr (ABES) · doi:10.70675/db1e0e4aza64dz4a25z9190z793416d0cc76
Influence of host proteins on the innate immune response to human adenoviruses in human phagocytes
Eichholz, K. (2015) · theses.fr (ABES) · doi:10.70675/d023bc3bz033bz4620z89f4z2d369db2e831
Autophagy in antigen presenting cells
Arbogast, F. (2018) · theses.fr (ABES) · doi:10.70675/34dc5979z744bz4dbcz8706z138eacecef37
Metadata
- Authors
- Kužnik, A., Benčina, M., Švajger, U., Jeras, M., Rozman, B., & Jerala, R.
- Affiliations
- National Institute of Chemistry (SI)
- Blood Transfusion Centre of Slovenia (SI)
- Ljubljana University Medical Centre (SI)
- University of Ljubljana (SI)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-04
- Volume
- 186
- Issue
- 8
- Pages
- 4794-4804
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2118400571
- Cited by
- 606
- References
- 40
- Citations by year
- 2026: 21 · 2025: 24 · 2024: 43 · 2023: 30 · 2022: 42 · 2021: 69 · 2020: 89 · 2019: 38 · 2018: 39 · 2017: 38 · 2016: 41 · 2015: 43 · 2014: 32 · 2013: 22 · 2012: 28
- FWCI
- 12.77
- Type
- journal article
- Language
- en
- Open access
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Repository of the University of Ljubljana (University of Ljubljana) (publishedVersion, other-oa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- antimalarial drugs, imidazoquinolines, chloroquine, hydroxychloroquine, quinacrine, TLR8, R848, nucleic acid binding, endosomal acidification, TLR9, TLR3, TLR7/8 agonist, systemic lupus erythematosus, autoimmune disease therapy, propidium iodide, bafilomycin
- MeSH terms
- Animals, Antimalarials, Binding, Competitive, Cell Line, Cells, Cultured, Chloroquine, Culture Media, Humans, Hydrogen-Ion Concentration, Imidazoles, Nucleic Acids, Quinacrine, Quinolines, Endosomes, Transfection, Cytokines, Serum, Toll-Like Receptors, Toll-Like Receptor 3, Toll-Like Receptor 7, Toll-Like Receptor 8, Toll-Like Receptor 9, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.